Visinin-like protein 1 regulates natriuretic peptide receptor B in the heart

Regulatory Peptides

Volumn 161, Issue 1-3, 2010, Pages 51-57

  Buttgereit, Jens ^a,b   Qadri, Fatimunnisa ^a,b   Monti, Jan ^a,b   Langenickel, Thomas H ^c   Dietz, Rainer ^b   Braunewell, Karl Heinz ^d   Bader, Michael ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c BRISTOL MYERS SQUIBB   (United States)

^d SOUTHERN RESEARCH INSTITUTE   (United States)

Author keywords

Cardiac hypertrophy; Heart failure; Natriuretic peptide receptor B; NPR B; VILIP 1; Visinin like protein 1

Indexed keywords

CALCIUM BINDING PROTEIN; NATRIURETIC PEPTIDE RECEPTOR B; UNCLASSIFIED DRUG; VISININ LIKE PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; HEART FAILURE; HEART MUSCLE CELL; HUMAN; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CELLS, CULTURED; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HEMODYNAMICS; HUMANS; IMMUNOHISTOCHEMISTRY; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; NEUROCALCIN; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ATRIAL NATRIURETIC FACTOR; RNA, SMALL INTERFERING;

RATTUS;

EID: 77950340104     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2009.12.019     Document Type: Article

References (43)

1. Braunewell K.H., Gundelfinger E.D. Intracellular neuronal calcium sensor proteins: a family of EF-hand calcium binding proteins in search of a function. Cell Tissue Res 1999, 295:1-12.
2. Ames J.B., Ishima R., Tanaka T., Gordon J.I., Stryer L., Ikura M. Molecular mechanisms of calcium-myristoyl switches. Nature 1997, 389:198-202.
3. Tzingounis A.V., Kobayashi M., Takamatsu K., Nicoll R.A. Hippocalcin gates the calcium activation of the slow after hyperpolarization in hippocampal pyramidal cells. Neuron 2007, 53:487-493.
4. Palmer C.L., Lim W., Hasti P.G., Toward M., Korolchuk V.I., Burbidge S.A., Banting G., Collingridge G.L., Isaac J.T., Henley J.M. Hippocalcin functions as a calcium sensor in hippocampal LTD. Neuron 2005, 47:487-494.
5. Kamide K., Kokubo Y., Yang J., Tanaka C., Hanada H., Takiuchi S., Inamoto N., Banno M., Kawano Y., Okayama A., Tomoike H., Miyata T. Hypertension susceptibility genes on chromosome 2p24-p25 in a general Japanese population. J Hypertens 2005, 23:955-960.
6. Braunewell K.H., Riederer P., Spilker C., Gundelfinger E.D., Bogerts B., Bernstein H.G. Abnormal localization of two neuronal calcium sensor proteins, visinin-like proteins (vilips)-1 and -3, in neocortical brain areas of Alzheimer disease patients. Dement Geriatr Cogn Disord 2001, 12:110-116.
7. Mahloogi H., Ganzález-Guerrico A.M., Lopez De Cicco R., Bassi D.E., Goodrow T., Braunewell K.H., Klein-Szanto A.J. Overexpression of the calcium sensor visinin-like protein-1 leads to a cAMP-mediated decrease of in vivo and in vitro growth and invasiveness of squamous cell carcinoma cells. Cancer Res 2003, 63:4997-5004.
8. Dai F.F., Zhang Y., Kang Y., Wang Q., Gaisano H.Y., Braunewell K.H., Chan C.B., Wheeler M.B. The neuronal Ca2+ sensor protein visinin-like protein-1 is expresses in pancreatic islets and regulates insulin secretion. J Biol Chem 2006, 281:21942-21953.
9. Brackmann M., Schuchmann S., Anand R., Braunewell K.H. Neuronal Ca2+ sensor protein VILIP-1 affects cGMP signalling of guanylyl cyclase B by regulating clathrin-dependent receptor recycling in hippocampal neurons. J Cell Sci 2005, 118:2495-2505.
10. Lin L., Jeanclos E.M., Treuil M., Braunewell K.H., Gundelfinger E.D., Anand R. The calcium sensor protein visinin-like protein-1 modulates the surface expression and agonist sensitivity of the alpha 4beta 2 nicotinic acetylcholine receptor. J Biol Chem 2002, 277:41872-41878.
11. Mathisen P.M., Johnson J.M., Kawczak J.A., Tuohy V.K. Visinin-like protein (VILIP) is a neuron-specific calcium-dependent double-stranded RNA binding protein. J Biol Chem 1999, 274:31571-31576.
12. Bernstein H.G., Becker A., Keilhoff G., Gorcyca W.A., Braunewell K.H., Grecksch G. Hippocampal expression of the calcium sensor protein VILIP-1 in schizophrenia. Neurosci Lett 2003, 339:95-98.
13. Braunewell K.H., Brackmann M., Manahan-Vaughan D. Group I mGlu receptors regulate the expression of the neuronal calcium sensor protein VILIP-1 in vitro and in vivo: implications for mGlu receptor-dependent hippocampal plasticity?. Neuropharmacology 2003, 44:707-715.
14. Gierke P., Zhao C., Kuhl D., Manahan-Vaughan D., Braunewell K.H. Expression analysis of members of the neuronal calcium sensor protein family: combining bioinformatics and Western blot analysis. Biochem Biophys Res Commun 2004, 322:1073-1079.
15. Silberbach M., Roberts C.T. Natriuretic peptide signalling: molecular and cellular pathways to growth regulation. Cell Signal 2001, 13:221-231.
16. Potter L.R., Abbey-Hosch S., Dickey D.M. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 2006, 27:47-72.
17. Langenickel T.H., Buttgereit J., Pagel-Langenickel I., Lindner M., Monti J., Beuerlein K., Al-Saadi N., Plehm R., Popova E., Tank J., Dietz R., Willenbrock R., Bader M. Cardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B. Proc Natl Acad Sci USA 2006, 103:4735-4740.
18. Rahmutula D., Cui J., Chen S., Gardner D. Transcriptional regulation of type B human natriuretic peptide receptor gene promoter: dependence on Sp1. Hypertension 2004, 44:283-288.
19. Abbey S.E., Potter L.R. Vasopressin-dependent inhibition of the C-type natriuretic peptide receptor, NPR-B/GC-B, requires elevated intracellular calcium concentrations. J Biol Chem 2002, 277:42423-42430.
20. Abbey S.E., Smirnov D., Potter L.R. Differential regulation of NPR-B/GC-B by protein kinase c and calcium. Biochem Pharmacol 2005, 70:686-694.
21. Lamounier-Zepter V., Ehrhart-Bornstein M., Karczewski P., Haase H., Bornstein S.R., Morano I. Human adipocyte attenuate cardiomyocyte contraction: characterization of an adipocyte-derived negative inotropic activity. FASEB J 2006, 20:1653-1659.
22. Dechend R., Homuth V., Wallukat G., Müller D.N., Krause M., Dudenhausen J., Haller H., Luft F.C. Agonistic antibodies directed at the angiotensin II, AT1 receptor in preeclampsia. J Soc Gynecol Investig 2006, 13:79-86.
23. Langenickel T., Buttgereit J., Pagel I., Dietz R., Willenbrock R., Bader M. Forced homodimerization by site-directed mutagenesis alters guanylyl cyclase activity of natriuretic peptide receptor B. Hypertension 2004, 43:460-465.
24. Philipp S., Jürgensen J.S., Fielitz J., Bernhardt W.M., Weidemann A., Schiche A., Pilz B., Dietz R., Regitz-Zagrosek V., Eckardt K.U., Eckardt K.U., Willenbrock R. Stabilization of hypoxia inducible factor rather than modulation of collagen metabolism improves cardiac function after acute myocardial infarction in rats. Eur J Heart Fail 2006, 8:347-354.
25. Braunewell K.H., Brackmann M., Schaupp M., Spilker C., Anand R., Gundelfinger E.D. Intracellular neuronal calcium sensort (NCS) protein VILIP-1 modulates cGMP signalling pathways in transfected neural cells and cerebellar granule neurons. J Neurochem 2001, 78:1277-1286.
26. Kishimoto I., Rossi K., Garbers D.L. A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy. Proc Natl Acad Sci USA 2001, 98:2703-2706.
27. Holtwick R., Van E.M., Skryabin B.V., Baba H.A., Bubikat A., Begrow F., Schneider M.D., Garbers D.L., Kuhn M. Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A. J Clin Invest 2003, 111:1399-1407.
28. Rosenkranz A.C., Woods R.L., Dusting G.J., Ritchie R.H. Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP. Cardiovasc Res 2003, 57:515-522.
29. Oliver P.M., Fox J.E., Kim R., Rockman H.A., Kim H.S., Reddick R.L., Pandey K.N., Milgram S.L., Smithies O., Maeda N. Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci USA 1997, 94:14730-14735.
30. Dickey D.M., Flora D.R., Bryan P.M., Xu X., Chen Y., Potter L.R. Differential regulation of membrane guanylyl cyclases in congestive heart failure: natriuretic peptide receptor (NPR-B)-B, Not NPR-A, is the predominant natriuretic peptide receptor in the failing heart. Endocrinology 2007, 148:3518-3522.
31. Soeki T., Kishimoto I., Okumura H., Tokudome T., Horio T., Mori K., Kangawa K. C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction. J Am Coll Cardiol 2005, 45:608-616.
32. Cody R.J., Atlas S.A., Laragh J.H., Kubo S.H., Covit A.B., Ryman K.S., Shaknovich A., Pondolfino K., Clark M., Camargo M.J., Scarborough R.M., Lewicki J.A. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal and hemodynamic responses to peptide infusion. J Clin Invest 1996, 78:1362-1374.
33. Tsutamoto T., Kanamori T., Morigami N., Sugimoto Y., Yamaoka O., Kinoshita M. Possibility of downregulation of natriuretic peptide receptor coupled to guanylyl cyclase in peripheral vascular beds of patients with chronic severe heart failure. Circulation 1993, 87:70-75.
34. Bryan P.M., Xu X., Dickey D.M., Chen Y., Potter L.R. Renal hyporesponsiveness to atrial natriuretic peptide in congestive heart failure results from reduced atrial natriuretic peptide receptor concentrations. Am J Physiol Renal Physiol 2007, 292:F1636-F1644.
35. Kim S.Z., Cho K.W., Kim S.H. Modulation of endocardial natriuretic peptide receptors in right ventricular hypertrophy. Am J Physiol 1999, 277:H2280-H2289.
36. Del Ry S., Cabiaty M., Lionetti V., Emdin M., Recchia F.A., Giannessi D. Expression of C-type natriuretic peptide and of its receptor NPR-B in normal and failing hearts. Peptides 2008, 29:2208-2215.
37. Andreassi M.G., Del Ry S., Palmieri C., Clerico A., Biagini A., Giannessi D. Up-regulation of "clearance" receptors in patients with chronic heart failure: a possible explanation for the resistance to biological effects of cardiac natriuretic hormones. Eur J Heart Fail 2001, 3:395-397.
38. Christoffersen T.E., Aplin M., Strom C.C., Sheikh S.P., Skott O., Busk P.K., Haunso S., Nielsen L.B. Increased natriuretic peptide receptor A and C gene expression in rats with pressure-overload cardiac hypertrophy. Am J Physiol Heart Circ Physiol 2006, 290:H1635-H1641.
39. Potter L.R., Garbers D.L. Protein kinase C-dependent desensitization of the atrial natriuretic peptide receptor is mediated by dephosphorylation. J Biol Chem 1994, 269:14636-14642.
40. Potter L.R. Phosphorylation-dependent regulation of the guanylyl cyclase-linked natriuretic peptide receptor B: dephosphorylation is a mechanism of desensitization. Biochemistry 1998, 37:2422-2429.
41. Bryan P.M., Potter L.R. The atrial natriuretic peptide receptor (NPR-A/GC-A) is dephosphorylated by distinct microcystin-sensitive and magnesium-dependent protein phosphatases. J Biol Chem 2002, 277:16041-16047.
42. Schlüter K.D., Piper H.M. Regulation of growth in the adult cardiomyocytes. FASEB J 1999, 13:17-22.
43. Tamura N., Garbers D.L. Regulation of the guanylyl cyclase-B receptor by alternative splicing. J Biol Chem 2003, 278:48880-48889.